2022
DOI: 10.1016/j.jcyt.2021.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 42 publications
0
4
0
1
Order By: Relevance
“…In fact, studies have demonstrated high post-thaw cell viability in cells cryopreserved using non-DMSO cryoprotectant compared with DMSO-cryopreserving cells. 47 , 48 In this study, we have cryopreserved the dissociated TG neurons using both DMSO and DMSO-free cryoprotectants (CryoScarless), respectively, using our optimized protocol described above. However, no cells were found attached in the CryoScarless preserved group (data not shown), suggesting that CryoScarless might not be suitable in the cryopreservation of neuronal cells.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, studies have demonstrated high post-thaw cell viability in cells cryopreserved using non-DMSO cryoprotectant compared with DMSO-cryopreserving cells. 47 , 48 In this study, we have cryopreserved the dissociated TG neurons using both DMSO and DMSO-free cryoprotectants (CryoScarless), respectively, using our optimized protocol described above. However, no cells were found attached in the CryoScarless preserved group (data not shown), suggesting that CryoScarless might not be suitable in the cryopreservation of neuronal cells.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, reducing the concentration of DMSO in the cryoprotective mixture to 5% effectively minimizes the amount of infused DMSO, resulting in a lower incidence of adverse events, without affecting hematopoietic recovery [ 39 ]. In the next future, new DMSO-free freezing media could replace DMSO and provide adequate cryoprotection to HSC grafts limiting toxicities to cells and recipients [ 40 ].…”
Section: Cryopreservation Of Hematopoietic Stem Cell Graftsmentioning
confidence: 99%
“…Имеются исследования, показывающие, что использование ДМСО снижает экспрессию факторов транскрипции, таких как Oct-4, Sox-2, Nanog и Rex-1, специфичных для эмбриональных стволовых клеток человека [48,49], а также влияние на эпигенетическое состояние клеток [50]. Предполагается, что добавление новых криопротекторов позволит улучшить жизнеспособность клеток после оттаивания и повысит успешность трансплантации [51].…”
Section: методология поискаunclassified